Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Hollenberg

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Archives of Biochemistry and Biophysics|November 10, 1995
Mechanism-based inactivation of cytochrome P450 2B1 by 9-ethynylphenanthreneE S Roberts, N E Hopkins, E J Zaluzec, et al.
Biochemistry|March 29, 1994
Identification of active-site peptides from 3H-labeled 2-ethynylnaphthalene-inactivated P450 2B1 and 2B4 using amino acid sequencing and mass spectrometryE S Roberts, N E Hopkins, E J Zaluzec, et al.
Biochemistry|September 6, 1994
Cytochrome P450-catalyzed hydroxylation of hydrocarbons: kinetic deuterium isotope effects for the hydroxylation of an ultrafast radical clockJ K Atkinson, P F Hollenberg, K U Ingold, et al.
Biochemistry|October 8, 1997
Significance of glycine 478 in the metabolism of N-benzyl-1-aminobenzotriazole to reactive intermediates by cytochrome P450 2B1U M Kent, I H Hanna, G D Szklarz, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
Identification of selective mechanism-based inactivators of cytochromes P-450 2B4 and 2B5, and determination of the molecular basis for differential susceptibilityS M Strobel, G D Szklarz, Y He, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 22, 2001
Differential induction of rat hepatic cytochromes P450 3A1, 3A2, 2B1, 2B2, and 2E1 in response to pyridine treatmentH Kim, D A Putt, R C Zangar, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 13, 2017
Functional characterization of the G162R and D216H genetic variants of human CYP17A1C P Capper, J Liu, L R McIntosh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 1997
Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarinsP Schmiedlin-Ren, D J Edwards, M E Fitzsimmons, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Archives of Biochemistry and Biophysics|November 10, 1995
Mechanism-based inactivation of cytochrome P450 2B1 by 9-ethynylphenanthreneE S Roberts, N E Hopkins, E J Zaluzec, et al.
Biochemistry|March 29, 1994
Identification of active-site peptides from 3H-labeled 2-ethynylnaphthalene-inactivated P450 2B1 and 2B4 using amino acid sequencing and mass spectrometryE S Roberts, N E Hopkins, E J Zaluzec, et al.
Biochemistry|September 6, 1994
Cytochrome P450-catalyzed hydroxylation of hydrocarbons: kinetic deuterium isotope effects for the hydroxylation of an ultrafast radical clockJ K Atkinson, P F Hollenberg, K U Ingold, et al.
Biochemistry|October 8, 1997
Significance of glycine 478 in the metabolism of N-benzyl-1-aminobenzotriazole to reactive intermediates by cytochrome P450 2B1U M Kent, I H Hanna, G D Szklarz, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
Identification of selective mechanism-based inactivators of cytochromes P-450 2B4 and 2B5, and determination of the molecular basis for differential susceptibilityS M Strobel, G D Szklarz, Y He, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 22, 2001
Differential induction of rat hepatic cytochromes P450 3A1, 3A2, 2B1, 2B2, and 2E1 in response to pyridine treatmentH Kim, D A Putt, R C Zangar, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 13, 2017
Functional characterization of the G162R and D216H genetic variants of human CYP17A1C P Capper, J Liu, L R McIntosh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 1997
Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarinsP Schmiedlin-Ren, D J Edwards, M E Fitzsimmons, et al.
Pageof 9